Edit
Curve Biosciences
http://curvebio.com/Last activity: 31.10.2025
Probably Closed - Reference to Redirection Page
Curve Biosciences (“Curve”) is a company unlocking the potential of Chronic Epigenetics to bring precision to chronic disease care. Curve creates products that target the biological changes in tissues that result in the development and progression of chronic diseases. Curve’s Whole Body Tissue Atlas (WBTA) uniquely allows the company to discover these precise changes with data from over 250,000 tissues across more than 1,000 clinical studies.
We are dedicated to improving our patients’ lives and supporting our employees’ dreams. Please reach out to contact@curvebio.com for more information.
We are dedicated to improving our patients’ lives and supporting our employees’ dreams. Please reach out to contact@curvebio.com for more information.
Location: United States,
Employees: 1-10
Total raised: $40M
Investors 2
| Date | Name | Website |
| - | NZVC | nzvc.co.nz |
| 11.06.2025 | First Spar... | firstspark... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.10.2025 | Series A | $40M | Incite Ven... |
Mentions in press and media 5
| Date | Title | Description |
| 31.10.2025 | Curve Biosciences Ignites New Era in Chronic Disease Care with $40M Funding | Curve Biosciences recently secured $40M in Series A funding. This capital fuels its Whole-Body Intelligence platform. The platform uses the proprietary Whole-Body Atlas, a vast collection of tissue samples. It powers advanced Whole-Body Blo... |
| 30.10.2025 | Curve Biosciences: $40 Million Raised To Advance Whole-Body Intelligence Platform for Chronic Disease Monitoring | Curve Biosciences, a biotechnology company pioneering Whole-Body Intelligence for proactive and personalized chronic disease care, has raised $40 million in new funding led by Luma Group, with participation from First Spark Ventures, Techas... |
| 29.10.2025 | Curve Biosciences Secures $40M to Launch Whole-Body Intelligence Platform | What You Should Know: – Curve Biosciences, the Whole-Body Intelligence™ company, today announced it has raised $40M in Series A funding led by Luma Group, with participation from First Spark Ventures, Techas Capital, Civilization Ventures, ... |
| - | Curve Biosciences | “curvebiosciences_vue” |
| - | Curve Biosciences | “Curve Bio is bringing precision to chronic disease care. ” |